Medical Device News Magazine

Florida Receives $4.3M to Help Rehabs Like Legacy Healing Center Combat the Opioid Epidemic

To provide "multifaceted support" for the treatment of opioid use disorder amidst the national opioid epidemic.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, is set to distribute an additional $4.3 million to organizations across Florida to provide “multifaceted support” for the treatment of opioid use disorder amidst the national opioid epidemic. So far, SAMHSA has provided $123 million nationally to help healthcare providers and communities combat substance use disorder.

The main focus of this round of funding for opioid use disorder treatment is for Medication-Assisted Treatment for Prescription Drug and Opioid Abuse (MAT-PDOA), also known as medically-assisted treatment (MAT).

MAT programs provide a highly effective long-term treatment for opioid use disorder.  MAT can have a lasting impact on brain function, by improving brain function and preventing relapse while simultaneously addressing the root causes of substance abuse through evidence-based behavioral therapies.

Florida remains a hotbed in the opioid epidemic.  The state saw an alarming 59 percent increase in drug overdose deaths from 2019 to 2020, according to preliminary data released in the Project Opioid Tampa Bay report which called the opioid problem in Florida “the epidemic within the pandemic”.

The impact of the COVID-19 pandemic on mental health, substance use disorder, and recovery is still being felt by individuals and communities across Florida. The government funding for effective treatment for opioid use disorder in Florida aims to help offset the devastation that the COVID-19 pandemic has had on addiction rates and to continue providing support to those suffering from opioid use disorder.

David Levin, Chief Clinical Officer and CEO of Legacy Healing Center which operates in Florida and New Jersey, commented on the effects of the COVID-19 pandemic on addiction.  “The disease of addiction metastasizes in isolation. And we are especially vulnerable and susceptible to depression, anxiety, and relapse because of the isolation, because of the quarantine, because of the fear, because of the disconnection. [The COVID-19 pandemic] has had a tremendous impact and it’s affecting everybody,” he said.

Legacy Healing Center, a SAMHSA-recognized addiction treatment center, provides MAT programs and holistic treatment models that can help a person out of addiction and mental health disorders. With the new round of funding for treatment, the professional help Floridians need to overcome opioid use disorder is now more available than ever.

Anyone struggling with substance abuse can speak to a treatment specialist at any time by calling (888) 534-2295.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”